default title

New Autism Experts Group Challenges Administration's Stance

2026-03-19

A newly established independent body comprising autism specialists is convening in Washington, D.C., this Thursday. Their primary objective is to challenge the current administration's perspective on autism spectrum disorder. This group seeks to offer a scientifically grounded alternative to the existing federal committee, which has recently seen new appointments by Robert F. Kennedy Jr., many of whom endorse the disproven theory linking vaccines to autism. The independent committee aims to steer the conversation back towards evidence-based research and effective support strategies for individuals with autism.

This new assembly, known as the Independent Autism Coordinating Committee, positions itself as a robust, science-driven counterpoint to the Interagency Autism Coordinating Committee, a federal entity. Their inaugural gathering follows closely on the heels of Health and Human Services Secretary Robert F. Kennedy Jr.'s selection of 21 new members for the federal panel. These appointees largely champion Kennedy's "Make America Healthy Again" initiative and share his discredited conviction regarding a causal link between vaccines and autism.

Helen Tager-Flusberg, a distinguished professor emerita at Boston University and director of the Center for Autism Research Excellence, also a member of this independent committee, voiced strong disapproval of the selection process for the federal panel. She, along with Alison Singer, president of the Autism Science Foundation and another member of the independent committee, asserted that the federal committee has been co-opted by a narrow ideological perspective. This agenda, they contend, neither genuinely represents the diverse autism community nor the current advancements in autism science.

The Independent Autism Coordinating Committee intends to concentrate its efforts on cutting-edge research concerning the etiology of autism and innovative ways to support individuals on the spectrum. Singer emphasized that dedicating resources to re-examine the vaccine-autism link diverts crucial funding from exploring actual causes. The committee's initial session was originally scheduled to coincide with a federal group meeting, which was subsequently postponed without explanation after the independent committee's plans became public. Nonetheless, the independent group proceeded with its meeting.

Singer plans to advocate for increased research into profound autism, which affects individuals who are nonverbal and require extensive support. She questions the applicability of current interventions for this population, noting that such interventions were often not validated with individuals experiencing profound autism. Tager-Flusberg will delve into the future of language and communication research in autism, particularly focusing on leveraging technology to enhance communication for those who cannot speak.

This initiative to form an independent autism committee mirrors a similar movement by scientists last year who expressed concerns over the administration's vaccine policies. The Vaccine Integrity Project, launched at the University of Minnesota, emerged after Kennedy's influence on the CDC's Advisory Committee on Immunization Practices. This project has collaborated with prominent medical organizations to issue its own vaccine guidelines. The independent autism committee will largely parallel its federal counterpart by advising on research and services, intending to submit reports to Congress and engage with major autism research funders like the National Institutes of Health and the Centers for Disease Control and Prevention. While acknowledging the independent committee's limited official authority compared to the federal government's resources, members highlight the increasing private funding for autism research, which they aim to guide effectively.

This newly formed independent expert panel on autism is committed to promoting scientific integrity and evidence-based approaches to understanding and supporting autism spectrum disorder. They aim to counteract the ideological biases perceived in the federal committee, championing rigorous research into the condition's causes and developing appropriate interventions, especially for individuals with profound autism. Despite their independent status, the committee seeks to influence policy and research funding by engaging with governmental bodies and non-governmental organizations, ensuring that resources are directed toward meaningful scientific discovery and effective support for the autistic community.

The burgeoning realm of 'private credit,' an increasingly prevalent yet often opaque lending mechanism to corporations outside traditional banking channels, is sparking considerable unease among financial stakeholders. Recent business failures of enterprises supported by private credit, coupled with a prominent private credit firm's asset divestiture triggering market apprehension, have cast a shadow over the stability of this estimated $3 trillion industry. There is mounting concern that the vulnerabilities within the private credit landscape, amplified by uncertainties surrounding the artificial intelligence sector, could precipitate broader financial instability, ultimately affecting individual investors and the global economic outlook.

Private credit involves non-bank entities, such as private-equity firms, extending loans to businesses that often struggle to secure financing from conventional banks due to perceived higher risks. While banks generally shy away from direct engagement with these riskier ventures, they nonetheless maintain exposure through their loans to the private credit firms themselves. This sector has experienced significant growth over several years, evolving into a substantial financial domain. However, its inherent problems are becoming increasingly apparent. A notable instance occurred in September when two companies financed by private credit declared bankruptcy, prompting questions about the diligence of private credit firms in evaluating borrowers and the mechanisms for recouping investments for both these firms and their financiers.

The current anxiety extends beyond isolated incidents. JPMorgan Chase CEO Jamie Dimon likened the situation to a 'cockroach' scenario, suggesting that more hidden issues are likely to emerge. This prediction has been substantiated in recent weeks, with additional vulnerabilities within the private credit sphere coming to light. For example, Blue Owl, a leading private credit provider, announced in February its plan to offload $1.4 billion in assets to return capital to investors. Far from providing reassurance, this announcement ignited widespread alarm regarding a potential depreciation of private credit assets, leading to a noticeable withdrawal of funds by investors from several private credit entities and a subsequent ripple effect on the stock market.

The market's reaction has been swift and severe, with Blue Owl's shares declining by approximately 40% since the year's commencement. Other major private credit players, including KKR, Apollo, and Blackstone, have also seen their stock values fall by 20% or more. Olaolu Aganga, head of portfolio construction for Citigroup's wealth-management division, observed that this collective rush to divest creates an 'inherent panic' that negatively influences market sentiment. This current period of financial distress is unfolding amidst a backdrop of fluctuating investor confidence, often swayed by factors like tariffs, the volatile AI boom, and geopolitical events such as the conflict in Iran and its impact on global oil prices.

A significant portion of the apprehension surrounding private credit is intricately linked to concerns about artificial intelligence. Despite the AI sector and major technology companies having propelled the stock market for years, investors are increasingly skeptical about the long-term profitability of these investments. Simultaneously, there is a pervasive fear that AI could render numerous software companies obsolete, a critical point given that private credit firms are major lenders to this very sector. Harvard law professor Jared Ellias highlighted the uncertainty, stating that 'everyone's terrified' about identifying future winners and losers. He expressed concern that private credit funds might be left with substantial losses if they have primarily financed companies that fail in the evolving tech landscape.

The implications of this private credit downturn are already being felt by ordinary individuals, particularly those whose retirement savings are invested in private credit companies through mutual funds or 401ks. A more profound concern for the general populace is the potential for these private credit issues to destabilize the broader financial system, potentially triggering a more extensive crisis. Experts and financial regulators frequently point to the sector's lack of transparency as a primary cause of this worry. Unlike banks, private credit firms are not subjected to the same rigorous regulatory oversight or mandated public disclosures regarding their lending practices and borrowers.

Brad Lipton, formerly a senior advisor at the Consumer Financial Protection Bureau and now director of corporate power and financial regulation at the Roosevelt Institute, emphasized the unknown extent of risks involved due to the lack of transparency. He warned that if investor confidence wanes and withdrawals accelerate, it could trigger a 'run' on these lending institutions, culminating in a crisis. Furthermore, Lipton and investors are apprehensive about the potential for private credit issues to contaminate the mainstream banking system, noting that U.S. banks have extended an estimated $300 billion in loans to private credit companies. This interconnectedness is evidenced by the recent sell-off in bank stocks, with the KBW Nasdaq Bank Index dropping over 11% since the beginning of the year, significantly underperforming the S&P 500.

Despite these concerns, Professor Ellias currently believes the situation is unlikely to escalate into a 2008-style financial meltdown, asserting that it represents a series of 'bad bets' by investors rather than a systemic failure of institutions like AIG or Lehman Brothers. His primary concern lies with the potential long-term negative impact on businesses, especially small and medium-sized enterprises that rely on private credit for funding when traditional bank loans are inaccessible. A prolonged slump in private credit could stifle the growth of these businesses, thereby slowing the overall economy. However, Ellias conceded that a cascade of poor investments could eventually undermine confidence across the financial markets, leading to 'contagion' and broader economic instability.